Arcellx (ACLX) Share-based Compensation (2021 - 2025)

Arcellx (ACLX) recorded quarterly Share-based Compensation of $18.1 million in Q4 2025, up 0.8% quarter-over-quarter from $17.9 million in Q3 2025, and up 14.6% on a YoY basis from $15.8 million in Q4 2024.

Arcellx (ACLX) Share-based Compensation (2021 - 2025) Analysis & Trends

Arcellx's Share-based Compensation history runs 5 years deep, the most recent figure standing at $18.1 million for Q4 2025.

  • In Q4 2025, Share-based Compensation rose 14.6% year-over-year to $18.1 million; the TTM figure through Dec 2025 stood at $77.9 million (up 27.51% YoY), while the FY2025 annual figure was $77.9 million, up 27.51% from the prior year.
  • Share-based Compensation was $18.1 million for Q4 2025 at Arcellx, up from $17.9 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $23.8 million in Q1 2025 to a low of $757000.0 in Q1 2021.
  • Historically, Share-based Compensation has averaged $10.5 million across 5 years, with a median of $10.5 million in 2023.
  • The sharpest annual moves came in 2022 and 2025: Share-based Compensation soared 491.94% in 2022, then gained 14.6% in 2025.
  • A 5-year view of Share-based Compensation shows it stood at $2.9 million in 2021, then jumped by 99.52% to $5.8 million in 2022, then soared by 83.33% to $10.6 million in 2023, then jumped by 48.55% to $15.8 million in 2024, then increased by 14.6% to $18.1 million in 2025.
  • The last three Share-based Compensation figures came in at $18.1 million (Q4 2025), $17.9 million (Q3 2025), and $18.1 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 305,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 166.40 Mn
9 Abivax 91.96 Bn 91.96 Bn - 26.47 Mn
10 Arcellx 6.48 Bn 6.48 Bn - 18.07 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 18.07 Mn
Dec 31, 2025 18.07 Mn
Sep 30, 2025 17.93 Mn
Sep 30, 2025 17.93 Mn
Jun 30, 2025 18.08 Mn
Jun 30, 2025 18.08 Mn
Mar 31, 2025 23.82 Mn
Mar 31, 2025 23.82 Mn
Dec 31, 2024 15.77 Mn
Dec 31, 2024 15.77 Mn
Sep 30, 2024 15.33 Mn
Sep 30, 2024 15.33 Mn
Jun 30, 2024 15.14 Mn
Jun 30, 2024 15.14 Mn
Mar 31, 2024 14.85 Mn
Mar 31, 2024 14.85 Mn
Dec 31, 2023 10.62 Mn
Dec 31, 2023 10.62 Mn
Sep 30, 2023 10.61 Mn
Sep 30, 2023 10.61 Mn